Press Releases
Pharmapack Drug Delivery Index hits record high
Pharmapack Europe 2023 (February 1-2) opens at Paris Expo, Porte de Versailles (Hall 7.2) with more than 5,500 attendees and over 300 companies expected as a new report and survey points...
Drug Research
South Korean Pharma Sector Attracts Despite Drug Nod Delays
According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow...
Press Releases
Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Andelyn Biosciences, Inc., a pioneering and patient-focused gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Odylia Therapeutics, a nonprofit 501(c)(3) biotech...
News
From February 13, FDA In-Person Session To Start Barring Few
FDA has recently announced that it is going to restart its in-person meetings that are face-to-face beginning February 13 with industry sponsors of biologics...
Drug Research
To Curb Medicine Inequality, 3-Year Novel Strategy Announced
A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability...
Drug Research
EC approves Regeneron-Sanofi’s Dupixent for eosinophilic esophagitis
The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE).
Dupixent’s expanded authorisation in the...
Drug Research
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. that serves as one of the company’s...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read